Expression of CD95 on mature leukocytes of MRL/lpr mice after transplantation of genetically modified bone marrow stem cells

Federzoni, Elena; Gordon, Grace; Müller, Stefan; Schmid, Inès; Simon, Hans-Uwe; Yousefi, Shida (2008). Expression of CD95 on mature leukocytes of MRL/lpr mice after transplantation of genetically modified bone marrow stem cells. Immunology letters, 117(1), pp. 45-9. Amsterdam: Elsevier 10.1016/j.imlet.2007.11.019

Full text not available from this repository. (Request a copy)

Bone marrow transplantation (BMT) is commonly used for the treatment of severe haematological and immunological diseases. For instance, the autoimmune lymphoproliferative syndrome (ALPS) caused by a complete expression defect of CD95 (Fas, APO-1) can be cured by allogeneic BMT. However, since this therapy may not generate satisfactory results when only partially compatible donors are available, we were interested in the development of a potential alternative treatment by using lentiviral gene transfer of a normal copy of CD95 cDNA in hematopoietic stem cells. Here, we show that this approach applied to MRL/lpr mice results in the expression of functional CD95 receptors on the surface of lymphocytes, monocytes, and granulocytes. This suggests that correction of CD95 deficiency can be achieved by gene therapy.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology

UniBE Contributor:

Simon, Hans-Uwe and Yousefi, Shida

ISSN:

0165-2478

ISBN:

18222547

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:02

Last Modified:

04 May 2014 23:18

Publisher DOI:

10.1016/j.imlet.2007.11.019

PubMed ID:

18222547

Web of Science ID:

000255183400006

URI:

https://boris.unibe.ch/id/eprint/26897 (FactScience: 93080)

Actions (login required)

Edit item Edit item
Provide Feedback